Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that bind to either PDL1, PD1, or CTLA4 to overcome this dampening down of the immune response, leading to better tumor cell kill by increased immune infiltration (54). The gene discussed is CD274; the disease is neoplasm.